RESUMEN
PURPOSE: The aim of this study was to evaluate the safety and efficacy of tacrolimus 0.1% eye drops in a large population of pediatric patients affected by a severe form of vernal keratoconjunctivitis (VKC) who responded poorly to cyclosporine eye drops. METHODS: This is a retrospective study based on standardized clinical charts and data collection of consecutive patients affected by severe VKC who responded poorly to cyclosporine eye drops topical treatment but treated with tacrolimus 0.1% eye drops with a follow-up of 18 months. Four clinical signs were graded for analysis: hyperemia, tarsal papillae, giant papillae, and limbal papillae. The blood tests for kidney and liver function and the tacrolimus level were studied. Visits were scheduled at baseline and at 3, 6, 12, and 18 months. Patients received tacrolimus 0.1% eye drops in both eyes 2 times daily. RESULTS: Four hundred thirty-one patients were included. Three hundred twenty-five patients were affected by a seasonal form, whereas the remaining 106 by a perennial form. Statistical analysis on each single score showed a positive relevance (P < 0.001) from baseline to all other visits. No local or systemic complications were recorded. CONCLUSIONS: Tacrolimus has been proposed as a treatment for severe forms of VKC. This study has confirmed the safety and efficacy of tacrolimus 0.1% eye drops in a large pediatric population of patients affected by a severe form of VKC who responded poorly to cyclosporine eye drops.
Asunto(s)
Conjuntivitis Alérgica/tratamiento farmacológico , Tacrolimus/administración & dosificación , Adolescente , Niño , Preescolar , Relación Dosis-Respuesta a Droga , Femenino , Estudios de Seguimiento , Humanos , Inmunosupresores/administración & dosificación , Masculino , Soluciones Oftálmicas , Estudios Retrospectivos , Resultado del TratamientoAsunto(s)
Proteínas en la Dieta/administración & dosificación , Enterocolitis/terapia , Hipersensibilidad a los Alimentos/terapia , Administración Oral , Alérgenos/inmunología , Proteínas en la Dieta/efectos adversos , Enterocolitis/inmunología , Femenino , Alimentos , Hipersensibilidad a los Alimentos/inmunología , Hospitales , Humanos , Lactante , Masculino , Estudios Retrospectivos , SíndromeRESUMEN
BACKGROUND: The therapeutic strategy for children with cow's milk allergy (CMA) consists in the elimination of cow's milk (CM) from their diet. Donkey's milk (DM) has been reported to be an adequate alternative, mainly to his nutritional similarities with human milk (HM) and excellent palatability. The aim of present prospective study was to evaluate the nutritional impact of DM on the diet of children with CMA in term of children growth. METHODS: Before the nutritional trial on children and during the study the health and hygiene risks and nutritional and nutraceuticals parameters of DM were monitored. Children with CMA were identified by the execution of in vivo and in vitro tests for CM and subsequent assessment of tolerability of DM with oral food challenge (OFC). Finally, we prescribed DM to a selected group of patients for a period of 6 months during which we monitored the growth of children. A total of 81 children, 70 with IgE mediated cow's milk protein allergy (IgE-CMPA) and 11 with Food Protein Induced Enterocolitis Syndrome to CM (CM-FPIES), were enrolled. RESULTS: Seventy-eight out of 81 patients underwent the OFC with DM and only one patient with IgE-CMPA (1.5 %) reacted. Twenty-two out of 81 patients took part of the nutritional trial. All the 22 patients took and tolerated the DM, moreover DM did not change the normal growth rate of infants. CONCLUSIONS: In conclusion, DM resulted safe in term of health and hygiene risks and nutritionally adequate: no negative impact on the normal growth rate of children was assessed. Therefore, it may be a suitable alternative for the management of IgE mediated CMA and FPIES, also in the first 6 months of life, if adequately supplemented.
Asunto(s)
Equidae , Hipersensibilidad a la Leche/prevención & control , Leche/inmunología , Adolescente , Animales , Bovinos , Niño , Preescolar , Femenino , Humanos , Lactante , Italia , Masculino , Hipersensibilidad a la Leche/inmunología , Estudios Prospectivos , Calidad de Vida , Pruebas CutáneasAsunto(s)
Proteínas en la Dieta/administración & dosificación , Enterocolitis , Hipersensibilidad a los Alimentos , Administración Oral , Niño , Preescolar , Proteínas en la Dieta/inmunología , Enterocolitis/diagnóstico , Enterocolitis/inmunología , Enterocolitis/patología , Femenino , Hipersensibilidad a los Alimentos/diagnóstico , Hipersensibilidad a los Alimentos/inmunología , Hipersensibilidad a los Alimentos/patología , Humanos , Lactante , Masculino , Estudios RetrospectivosRESUMEN
Purpose: The aim of the present prospective study was to evaluate the lacrimal fluid concentration of HMGB1 in young patients affected by Vernal Keratoconjunctivitis (VKC) compared to a control group of healthy subjects of same age. Methods: Tear fluids was collected in a group of VKC patients and compared to a control group of healthy subjects. HMGB1 concentration was measured using the HMGB1 ELISA II test both in VCK and control subjects. Results: The mean concentration of HMGB1 in tear fluids of 45 VKC patients was 0,977 ± 0,72 ng/ml whereas in the control group was 0,24 ± 0,25 ng/ml and the difference was statistically significant (p = 0,000106) Conclusion: The concentration of HMGB1 in VCK patients was found to be significantly increased, suggesting a possible role of this protein in the inflammatory mechanism of VKC.
Asunto(s)
Conjuntivitis Alérgica/metabolismo , Proteína HMGB1/metabolismo , Aparato Lagrimal/metabolismo , Adolescente , Estudios de Casos y Controles , Niño , Estudios Transversales , Ensayo de Inmunoadsorción Enzimática , Femenino , Humanos , Masculino , Estudios Prospectivos , Lágrimas/metabolismoRESUMEN
BACKGROUND: Hazelnut allergy (HA) is one of the more common food allergies (FAs) in Europe with a prevalence of 0.2%. The gold standard for diagnosing FA is oral food challenge (OFC) with the culprit food. Another purpose of OFC is to identify the "threshold level" of food as the dose that elicits symptoms. In this way it is possible to avoid a strict elimination diet and to determine the minimal quantity of the culprit food tolerated by the patient. OBJECTIVE: The aim of our study was to assess the efficacy and tolerability of hazelnut low-dose OFC (H-LDOFC) in children with HA. METHODS: From January 2015 to December 2016, we retrospectively analyzed the charts of patients referred to Allergy Unit of Meyer Children's Hospital, Florence, Italy for a history of HA. Prick by prick (PbP) and specific serum IgE (s-IgE) to hazelnut were performed. We proposed conducting an H-LDOFC to parents of children with HA. The H-LDOFC was considered completed when a cumulative dose of 2.5 g of hazelnut was reached. We divided the patients who underwent the H-LDOFC into an asymptomatic and a symptomatic group. For statistics we used SPSS for Windows version 16.0 and conducted a t test for comparing the averages, considering a p value of < 0.05 significant. RESULTS: Forty-three out of 70 patients (61.4%) with HA underwent an H-LDOFC. The PbP to hazelnut (mean ± SD) was 7.2 ± 2.9 mm and the s-IgE to hazelnut 25.3 ± 32.5 kU/L. Twenty-eight out of the 43 patients (65.1%) who underwent H-LDOFC reached the cumulative dose of 2.5 g of hazelnut. During the H-LDOFC, 20/43 patients (46.5%) had no reactions and 23/43 patients had a total of 55 reactions: 34 (61.8%) oral allergy syndrome, 8 (14.5%) rash, 6 (10.9%) abdominal pain, 2 (3.6%) urticaria, 2 (3.6%) angioedema, and 3 (5.4%) dyspnea. Atopic dermatitis was found to present the only statistically significant difference (p = 0.002) in patients with symptoms compared to asymptomatic patients during H-LDOFC. CONCLUSIONS: To our knowledge, this was the first study to assess the efficacy and tolerability of H-LDOFC in a pediatric population. Our study suggests that in children with HA, H-LDOFC is well accepted and safe because adverse reactions are mild and the majority are represented by localized symptoms (oral allergy syndrome) and efficient, especially in terms of improvement of quality of life. For these reasons it could be more extensively used in the treatment of HA.
Asunto(s)
Alérgenos/efectos adversos , Corylus/efectos adversos , Desensibilización Inmunológica , Tolerancia Inmunológica , Hipersensibilidad a la Nuez/inmunología , Hipersensibilidad a la Nuez/terapia , Adolescente , Alérgenos/administración & dosificación , Niño , Preescolar , Femenino , Humanos , Inmunoglobulina E/inmunología , Masculino , Hipersensibilidad a la Nuez/diagnóstico , Estudios Retrospectivos , Pruebas Cutáneas , Resultado del TratamientoAsunto(s)
Hipersensibilidad a la Leche/inmunología , Proteínas de la Leche/inmunología , Leche/inmunología , Adolescente , Animales , Bovinos , Niño , Preescolar , Equidae , Femenino , Humanos , Inmunoglobulina E/sangre , Lactante , Italia , Masculino , Leche/efectos adversos , Hipersensibilidad a la Leche/dietoterapia , Estudios Prospectivos , Pruebas Cutáneas/métodosRESUMEN
Oral immunotherapy (OIT) has been introduced as a new immune-modulating treatment under investigation for food allergies. The aim of our study was to evaluate the success of OIT in a cohort of children with milk allergy. These children underwent OIT in a clinical practice and were followed for up to ten years. The secondary endpoint was to describe the main adverse events during OIT and compare them to those reported in the literature. Eighty-two milk-allergic children started OIT. According to the OIT endpoint reached after one year, all of the children enrolled in the study were divided into four groups: complete desensitization; partial desensitization; step down; and stop groups. Any adverse events that occurred during OIT were also recorded. Of the 82 patients, eight were recruited in the last months of 2010 so they were still ongoing at the end of the study. For that reason, they were excluded from the analysis. The majority (73%) of the 74 children evaluated (51 boys, 23 girls; median age, 7 years; age range, 2-18 years; specific serum IgE for cow's milk, 36 KUA/L [range, 3-100 KUA/L]; milk SPT wheal diameter, 7 mm [range, 2-15 mm]) reached complete (58.1%) or partial (14.9%) desensitization, 9.4% were subjected to step down. The remaining 17.6% of the children discontinued OIT because of the occurrence of chronic gastroenteric (GE) symptoms (46.1%) or acute asthma (15.3%) following milk intake. In agreement with the literature, we found that chronic GE symptoms was the main reason for OIT discontinuation. OIT represents a valid tool for the treatment of food allergies in children; however, the risk of potential adverse reactions, both IgE- and non-IgE-mediated, should be discussed with parents prior to the initiation of OIT.
Asunto(s)
Desensibilización Inmunológica/efectos adversos , Hipersensibilidad a la Leche/terapia , Administración Oral , Adolescente , Animales , Niño , Preescolar , Femenino , Humanos , Inmunoglobulina E/sangre , Masculino , Leche/inmunología , Hipersensibilidad a la Leche/sangre , Resultado del TratamientoRESUMEN
BACKGROUND: The basophil activation test (BAT), has been proposed as a possible assay for the diagnosis of immediate-type allergy to beta-lactams (BLs). The aim of this study was to assess the utility of BAT in the diagnosis of amoxicillin (AMX) or AMX-clavulanate (AMX-C) IgE-mediated hypersensitivity in children and adults. MATERIAL AND METHODS: Eighteen children and 21 adults, with clinical history of immediate reactions to AMX or AMX-C, were referred to Anna Meyer Children's Hospital and San Giovanni di Dio Hospital, respectively. They underwent in vivo tests (skin prick test and intradermal test). Moreover, BAT with AMX or AMX-C was performed within 6 months from the reaction. RESULTS: In the pediatric group, the concordance between the skin tests (ST) and BAT results was 83.3%. Upon comparing the symptom grades and ST results to the BAT results, we found that the reaction severity and ST positivity did not correlate with BAT results in children. In the adult group, the concordance between the ST and BAT results was 61.9%. Upon comparing patients with severe reactions and patients with mild reactions in terms of BAT results, we found a BAT sensitivity of 38.5% and a specificity of 100%. When comparing the symptom grades to the BAT results, we found that no patients with mild symptoms had a positive BAT result, whereas 38.5% of patients with severe symptoms had a positive BAT result. CONCLUSIONS: BAT does not seem to be a useful tool to increase the sensitivity of an allergy work-up to diagnose immediate hypersensitivity to AMX or AMX-C.
Asunto(s)
Combinación Amoxicilina-Clavulanato de Potasio/inmunología , Amoxicilina/inmunología , Basófilos/efectos de los fármacos , Hipersensibilidad a las Drogas/diagnóstico , Hipersensibilidad Inmediata/diagnóstico , Adolescente , Adulto , Factores de Edad , Amoxicilina/administración & dosificación , Combinación Amoxicilina-Clavulanato de Potasio/administración & dosificación , Basófilos/inmunología , Niño , Preescolar , Estudios de Cohortes , Bases de Datos Factuales , Hipersensibilidad a las Drogas/inmunología , Femenino , Humanos , Hipersensibilidad Inmediata/inmunología , Pruebas Inmunológicas/métodos , Masculino , Estudios Retrospectivos , Medición de Riesgo , Sensibilidad y Especificidad , Pruebas CutáneasRESUMEN
Non-steroidal anti-inflammatory drugs are suspected to cause drug hypersensitivity very frequently in paediatric patients. In this article, we describe the first case of anaphylaxis to flurbiprofen in a child and provide insight into the possibility of severe reactions and even anaphylaxis to over-the-counter flurbiprofen. Finally, the importance of a rigorous allergy work-up in reaching a confident diagnosis and providing the patient with a safe alternative is shown.
Asunto(s)
Anafilaxia/inducido químicamente , Anafilaxia/diagnóstico , Antiinflamatorios no Esteroideos/efectos adversos , Flurbiprofeno/efectos adversos , Medicamentos sin Prescripción/efectos adversos , Niño , Femenino , HumanosRESUMEN
PURPOSE: To evaluate the prevalence of keratoconus (KC) and other corneal abnormalities by means of videokeratography and tomography in a large series of patients affected by vernal keratoconjunctivitis (VKC). DESIGN: Cross-sectional study. METHODS: Setting: Single-center children's hospital. STUDY POPULATION: A total of 651 consecutive patients with VKC and a control group of 500 were prospectively recruited between May 1, 2012 and September 30, 2013, with a minimum follow-up of 12 months. OBSERVATION PROCEDURE: All patients were evaluated by means of a Scheimpflug camera combined with a Placido corneal topographer. Keratoconus, suspected keratoconus, or its absence were determined in each patient. The corneal symmetry index of front (SIf) and back curvature (SIb), shape indices, and thicknesses were compared between the 2 groups. MAIN OUTCOME MEASURES: Prevalence of keratoconus and corneal indices modifications. RESULTS: Five out of 651 patients (0.77%) demonstrated topographic signs of KC. Two of them were bilateral. All patients were older than 7 years of age, and the mean age was 11.54 years. Four other patients (0.61%) were classified as KC suspects by the screening program. Of 304 patients older than 11 years (mean age 14.4 years), 4 (1.32%) were found to have KCN, and 4 (1.32%) were KC suspects. The corneal indices of patients in the VKC group were extremely similar to those in the control group. (P > .05). CONCLUSIONS: The prevalence of KC in our patient population, compared with previous reports in the literature, is much lower. The similar corneal indices in both groups suggest the absence of permanent corneal deformation due to VKC.
Asunto(s)
Conjuntivitis Alérgica/complicaciones , Córnea/patología , Topografía de la Córnea/métodos , Queratocono/epidemiología , Adolescente , Niño , Conjuntivitis Alérgica/diagnóstico , Estudios Transversales , Femenino , Estudios de Seguimiento , Humanos , Italia/epidemiología , Queratocono/diagnóstico , Queratocono/etiología , Masculino , Prevalencia , Estudios Retrospectivos , Adulto JovenAsunto(s)
Combinación Amoxicilina-Clavulanato de Potasio/efectos adversos , Erupciones por Medicamentos/diagnóstico , Fiebre/diagnóstico , Adolescente , Combinación Amoxicilina-Clavulanato de Potasio/administración & dosificación , Antibacterianos/administración & dosificación , Antibacterianos/efectos adversos , Erupciones por Medicamentos/etiología , Hipersensibilidad a las Drogas/diagnóstico , Hipersensibilidad a las Drogas/etiología , Hipersensibilidad a las Drogas/fisiopatología , Femenino , Fiebre/etiología , Humanos , Pruebas Inmunológicas/métodos , Manejo de Atención al Paciente/métodos , Pruebas Cutáneas/métodosRESUMEN
Hypersensitivity reactions to tramadol are rare and the drug is commonly considered safe. Here, we report the first case of anaphylaxis to tramadol in a child. We point out the difficulty in reaching a confident diagnosis when testing opioid alkaloid drugs with histamine-releasing properties. Additionally, we showed the importance of a well-performed allergy work-up, especially when testing drugs with low experience and when standardized concentrations have not been tested. Moreover, this case provides insight into the possibility of severe reactions, and even anaphylaxis, to tramadol.
Asunto(s)
Analgésicos Opioides/efectos adversos , Anafilaxia/inducido químicamente , Tramadol/efectos adversos , Adolescente , Analgésicos Opioides/administración & dosificación , Analgésicos Opioides/uso terapéutico , Anafilaxia/diagnóstico , Humanos , Inmunoglobulina E/sangre , Inyecciones Intravenosas , Pruebas Intradérmicas , Masculino , Tramadol/administración & dosificación , Tramadol/uso terapéuticoRESUMEN
Although several cases of severe hypoalbuminemia resulting from rice milk have been described in the past, today the use of rice milk without nutritional counseling to treat eczema is still a continuing, poor practice. We describe a kwashiorkor case in an infant with severe eczema exclusively fed with rice milk. It is well documented that rice milk is not a sufficient protein source. Moreover, only a small portion of eczema is triggered by food allergy. In conclusion this case raises the importance of managing dietary changes facing food allergies with responsibility for specialized consensus among pediatricians, nutritionists, endocrinologists and allergists all of them specialist professionals.
Asunto(s)
Dermatitis Atópica/dietoterapia , Hipoalbuminemia/inducido químicamente , Kwashiorkor/inducido químicamente , Oryza/efectos adversos , Calcio de la Dieta/administración & dosificación , Calcio de la Dieta/sangre , Dieta , Proteínas en la Dieta/administración & dosificación , Ácido Fólico/administración & dosificación , Hipersensibilidad a los Alimentos/dietoterapia , Frutas , Humanos , Hipoalbuminemia/diagnóstico , Hipoalbuminemia/patología , Inmunoglobulina E/sangre , Lactante , Hierro de la Dieta/administración & dosificación , Kwashiorkor/diagnóstico , Kwashiorkor/patología , Masculino , Albúmina Sérica/metabolismo , Verduras , Vitamina K/administración & dosificaciónRESUMEN
Although reversible H2 receptor antagonists are usually well tolerated, there are few reports on anaphylactic reactions triggered by ranitidine. Here we report the first case of anaphylaxis to ranitidine in a child. This was an IgE-mediated event occurring in a patient who had never used ranitidine before.
Asunto(s)
Anafilaxia/inducido químicamente , Antiulcerosos/efectos adversos , Ranitidina/efectos adversos , Administración Intravenosa , Ampicilina/uso terapéutico , Antibacterianos/uso terapéutico , Niño , Colecistitis Aguda/tratamiento farmacológico , Humanos , Masculino , Sulbactam/uso terapéuticoRESUMEN
BACKGROUND: Vernal keratoconjunctivitis (VKC) is a chronic sight-threatening ocular disease. Topical cyclosporine A (Cyc) has been widely administered as a steroid-sparing drug, although in about 7-10% of cases, it has been ineffective. The purpose of this study was to evaluate the efficacy of 0.1% topical tacrolimus (Tcr) in patients with severe VKC who failed to respond to 1% Cyc eyedrops. METHODS: Consecutive patients with severe, Cyc-resistant VKC were enrolled in a double-blind, comparative, crossover (DBCO) trial; all patients were treated with 1% Cyc in one eye and 0.1% Tcr in the other eye for 3 wk. After a washout period of 7 days, patients were instructed to cross over the medications for three additional weeks. Objective ocular score, subjective score, and quality-of-life questionnaires (QoLQ) were collected during the trial. Blood samples were drawn to assess several safety parameters. RESULTS: Thirty patients have been enrolled (mean age 9.05 ± 2.12 yr). In each of the two phases of the DBCO trial, a significant improvement in objective and subjective scores was observed in the eyes treated with 0.1% Tcr (p < 0.001). Likewise, the quality of life significantly improved despite only half the eyes being successfully treated. Serum creatinine and blood parameters were constantly within the normal range, and both blood Cyc and Tcr concentrations remained below the lowest detectable levels. CONCLUSIONS: Topical Tcr is very effective and safe in the short term for patients suffering from severe VKC resistant to topical Cyc.
Asunto(s)
Conjuntivitis Alérgica/tratamiento farmacológico , Ciclosporina/administración & dosificación , Ojo/efectos de los fármacos , Soluciones Oftálmicas/administración & dosificación , Tacrolimus/administración & dosificación , Niño , Creatinina/sangre , Estudios Cruzados , Ciclosporina/efectos adversos , Progresión de la Enfermedad , Método Doble Ciego , Resistencia a Medicamentos , Femenino , Humanos , Masculino , Calidad de Vida , Tacrolimus/efectos adversosRESUMEN
BACKGROUND: The drug provocation test (DPT) is the gold standard to rule out drug hypersensitivity. There are standardized DPT protocols to diagnose immediate reactions to drugs, but not for nonimmediate reactions. OBJECTIVE: The aim of this study was to show the sensitivity and specificity of an allergy work-up that included a 5-day DPT in children with histories of nonimmediate reactions to amoxicillin through focusing on a pediatric population with histories of immediate and nonimmediate reactions to amoxicillin. METHODS: Two hundred consecutive patients with histories of amoxicillin reactions referred to the Allergy Unit of Anna Meyer Children's Hospital for suspected drug allergy from 2008 to 2011 underwent in vivo tests with the culprit drug according to European Academy of Allergy and Clinical Immunology guidelines. Moreover, most of those children, regardless of the skin tests results, were challenged with amoxicillin for a total of 5 days. RESULTS: In 4 years, 200 patients were evaluated for a history of drug hypersensitivity to amoxicillin. The majority of patients (76%) had a history of mild nonimmediate reactions. All 200 patients underwent skin tests, and 9 of 200 tested positive. A total of 177 DPTs were performed with amoxicillin for 5 days in each child. Diagnosis of amoxicillin allergy was confirmed by a DPT in 17 patients (9.6%); 14/17 had history of nonimmediate reactions; 4/14 (26.6%) reacted on day 5. CONCLUSION: According to our results, a long-term DPT protocol increases the sensitivity of the allergy work-up, and it should be recommended for patients with a history of amoxicillin nonimmediate reaction.
Asunto(s)
Amoxicilina/administración & dosificación , Amoxicilina/efectos adversos , Antibacterianos/administración & dosificación , Antibacterianos/efectos adversos , Erupciones por Medicamentos/diagnóstico , Pruebas Inmunológicas/métodos , Adolescente , Biomarcadores/sangre , Niño , Preescolar , Esquema de Medicación , Erupciones por Medicamentos/sangre , Erupciones por Medicamentos/inmunología , Femenino , Hospitales Pediátricos , Humanos , Inmunoglobulina E/sangre , Lactante , Masculino , Valor Predictivo de las Pruebas , Medición de Riesgo , Factores de Riesgo , Pruebas Cutáneas , Factores de TiempoRESUMEN
INTRODUCTION: Vernal keratoconjunctivitis (VKC) is a chronic conjunctivitis that mainly affects children living in temperate areas. The notable difference between genders and VKC's resolution with puberty have persistently suggested a role of hormonal factors in VKC development. OBJECTIVE: To describe six cases of males with VKC and growth hormone deficiency (GHD) reported as a long-term follow-up during rhGH treatment. METHODS: Six consecutive male patients (median age at GHD diagnosis 9.7, range 7.9 to 13.1 years) with VKC, were recruited from July 2005 to July 2013 at the Paediatric Endocrinology Unit of Anna Meyer Children's Hospital in Florence, Italy. In these patients, anthropometric data were collected periodically. In three of these patients, data were collected to near-adult or adult height. RESULTS: Familial history was uneventful for all patients. The target height was normal, ranging from 0.65 standard deviation scores (SDS) to 2.01 SDS. The patients showed a normal birth-weight (from -1.21 to 1.35 SDS) and birth-length (from -0.93 to 1.21 SDS). At GHD diagnosis, all of the patients exhibited demonstrated important growth retardation (from -2.05 to -2.78 SDS). Plasmatic concentrations of IGF-1 and IGFBP-3 were low (from -1.85 to -3 SDS and from -1.81 to -2.76 SDS, respectively). GH stimulation tests showed classic GHD symptoms in all of the patients. Pubertal onset was normal. All of the patients treated with rhGH responded well to rhGH treatment. Adult height, evaluated in three patients, was in accordance with their target height. CONCLUSIONS: To our current knowledge, we have described for the first time six patients affected by VKC with GH deficiency, in some of whom we performed a long-term follow-up to adult height. Further studies will be needed to establish whether GHD may be a common feature of VKC patients. Nevertheless, it appears to be useful to carefully follow statural growth of VKC patients, while the possibility of a GH deficiency must to be taken into account in the presence of growth failure.
Asunto(s)
Conjuntivitis Alérgica/epidemiología , Trastornos del Crecimiento/epidemiología , Hormona de Crecimiento Humana/deficiencia , Adolescente , Adulto , Factores de Edad , Biomarcadores/sangre , Estatura/efectos de los fármacos , Niño , Conjuntivitis Alérgica/diagnóstico , Trastornos del Crecimiento/sangre , Trastornos del Crecimiento/diagnóstico , Trastornos del Crecimiento/tratamiento farmacológico , Trastornos del Crecimiento/fisiopatología , Terapia de Reemplazo de Hormonas , Hormona de Crecimiento Humana/sangre , Hormona de Crecimiento Humana/uso terapéutico , Humanos , Italia/epidemiología , Masculino , Prevalencia , Proteínas Recombinantes/uso terapéutico , Factores de Tiempo , Resultado del TratamientoRESUMEN
Hormones may play a role in the pathophysiology of vernal keratoconjunctivitis (VKC). An increased incidence of thyroid autoantibodies was recently observed in VKC, although there were no data on thyroid function. Two hundred and eighty-eight patients (202 males, 86 females; range 5.5 to 16.9 years) with VKC were evaluated and compared with 188 normal age- and sex-matched subjects. In all subjects, serum concentrations of free T4, TSH, thyroperoxidase, thyroglobulin, and TSHr autoantibodies were evaluated. In VKC, the family history of thyroid diseases showed no significant differences compared to the controls (9.4 versus 8.6%), whereas the family history of autoimmune diseases was significantly higher (13.2% versus 6.3%; P<0.05). Subclinical hypothyroidism was diagnosed in 6.6% (versus 1.6% of the controls; P<0.05) and overt hypothyroidism in 0.7% (versus 0.0% of the controls; P = NS). Finally, 5.2% of patients were positive for thyroid autoantibodies, which were significantly higher with respect to the controls (0.5%, P<0.05). In the patients positive for thyroid autoantibodies, 80% showed a sonography pattern that suggested autoimmune thyroiditis. Thyroid function and autoimmunity abnormalities are frequently present in children with VKC. Children with VKC should be screened for thyroid function and evaluated for thyroid autoimmunity.